Physician profile
Todd C Schaeffer
NPI 1922098367
$796.74
in general payments reported to CMS, 2019-2025
9 companies · $95.05 in 2025
The $95.05 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $18.36 · 2022: $38.07 · 2023: $163 · 2024: $218 · 2025: $95.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Consulting Fee: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.91 |
| Consulting Fee | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $131.25 | 2019 | |
| Grifols USA, LLC | $127.89 | 2020-2025 | Xembify |
| Stryker Corporation | $114.68 | 2023-2025 | Xpress Ent Dilation System, Clarifix Cryotherapy Device, Xerogel Nasal/Epistaxis 2 Pack |
| Merck Sharp & Dohme LLC | $106.92 | 2019 | |
| Medtronic, INC. | $88.50 | 2024 | Propel |
| Glaxosmithkline, LLC. | $79.30 | 2024 | |
| Neurent Medical Limited | $71.97 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Rivanna Medical, INC | $50.00 | 2024 | Accuro |
| Bard Access Systems, INC. | $26.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.